Kendle International Inc.

Candace Kendle, PharmD, is Chairman and Chief Executive Officer at Kendle International Inc., one of the world's leading global clinical research organizations (CROs). The company focuses on bringing new live-saving and life-enhancing drugs to market for the benefit of patients worldwide. Since co-founding Kendle in 1981, she has provided the overall vision and strategy to grow the company from a small consulting business into one of the largest providers of clinical development solutions for the biopharmaceutical industry. Today, Kendle is one of the few truly global CROs, with operations spanning North America, Europe, Asia/Pacific, Latin America and Africa. The company currently operates in 51 locations throughout 28 countries and employs more than 4,000 associates. Kendle is one of only three CROs to derive more than 50 percent of its revenue from outside North America. In 2008, Kendle was named to the FORTUNE Magazine list of the 100 fastest-growing companies in the United States. The company posted 2008 net service revenue of $475.1 million, a 19 percent increase year-over-year. Dr. Kendle is recognized worldwide as leader in the CRO industry. She is a founding member and past chairperson of the Association of Clinical Research Organizations (ACRO), which fosters continued advancement of medical product development and expedites the introduction of new medicines and new treatments to improve health and save lives. She also is a member of the Committee of 200, an organization of preeminent women entrepreneurs and corporate leaders, and has received numerous civic, financial and pharmaceutical industry leadership awards.

Christopher Bergen co-founded Kendle in 1981 and served as a Director and as President and Chief Operating Officer since its incorporation in 1997. As COO, Mr. Bergen is leading our infrastructure expansion to support the company's projected future growth and drive improved global connectivity. Currently he provides leadership for the company's global Enterprise Resource Planning initiative, Project Management Office and Commercial Operations. Prior to Kendle, Mr. Bergen served in various capacities at The Children's Hospital of Philadelphia, ending his tenure as Associate Vice President.

As President, Simon Higginbotham provides global leadership for worldwide customer and business expansion, including strategic customer relations and new market opportunities. He served as Vice President and Chief Marketing Officer for the company from January 2004 until April 2008 and has been a key member of its executive team since joining the company in 2004. During his tenure, Kendle has consistently reported record sales, delivering growth at double, triple and double again the reported sector growth rate for Phase I-IV services in 2007, 2006 and 2005, respectively. As a result, the company was recognized as the "2006 North American Contract Research Organization Business Development Strategy Leader of the Year" by global growth consulting company Frost & Sullivan. Mr. Higginbotham has more than 25 years of experience and success in senior leadership positions in the CRO and biopharmaceutical industries. He currently represents Kendle on the Board of Directors of the Association of Clinical Research Organizations (ACRO). In 2008, Mr. Higginbotham completed the Harvard Business School Advanced Management Program.

Frederick A. Russ, PH.D., 64, has served as a director of the Company since November 2002. Dr. Russ is currently Professor of Marketing at the University of Cincinnati. He previously served as the Senior Vice Provost for the University of Cincinnati from October 2004 until 2007. From 1994 through September 2004, he was Dean of the College of Business there. He also serves on the Board of Directors of Charles & Colvard, Ltd., a manufacturer and supplier of specialty jewelry and formerly served as its non-executive Chairman of the Board. His professional experience also includes 18 years at the University of North Carolina, membership on the founding Board of Directors of Cree Inc., an advanced materials company and consulting in marketing and marketing research to a wide variety of organizations. He as co-authored three textbooks and has written numerous articles on marketing strategy and the behavior of consumers and sales personnel.

G. Steven Geis, PhD, MD, has served as a director of Kendle since November 2002. Now retired, Dr. Geis served in a number of management and senior management positions with Searle and the Pharmacia Companies from 1985 to July 2002. He most recently served as Group Vice President: Arthritis, Cardiovascular and Oncology Clinical Development from March 2001 through July 2002 and Vice President: Arthritis Clinical Development from August 1998 through March 2001. He has authored or co-authored numerous journal articles covering several therapeutic areas.

Mr. Buck joined us as President and Chief Executive Officer in October 2003 and was appointed as Chairman of the Board in March 2007. Prior to joining us, he served as President—Uniform Rental Division of Cintas Corporation from 1997 to 2003. From 1991 through 1997, he served as Senior Vice President—Midwest Region of Cintas. From 1982 through 1991, he served as Senior Vice President—Finance and Chief Financial Officer of Cintas. Mr. Buck presently serves as a director of Kendle International, Inc. and Multi-Color Corporation, both of which are Nasdaq-traded companies, and privately-held LVI Services, Inc.